Clinical Approach to Ataxia
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of Ataxia
Ataxia is one of the most important neurological signs encountered in clinical practice, affecting approximately 150,000 people in the United States alone. The inherited ataxias have a combined prevalence of approximately 10 per 100,000, while acquired ataxias are considerably more common, with cerebellar stroke accounting for approximately 2-3% of all strokes. Ataxia can be the presenting feature of numerous conditions ranging from benign and self-limiting to rapidly progressive and life-threatening. Recognition of the type of ataxia and its temporal profile is essential for guiding the diagnostic workup and identifying treatable causes.
Definition
Ataxia (from Greek “a-” meaning without, and “taxis” meaning order) is a neurological sign consisting of lack of voluntary coordination of muscle movements. It manifests as impaired coordination of gait, limb movements, speech, and eye movements, resulting from dysfunction of the cerebellum, its connections, sensory pathways, or vestibular system. Ataxia is a sign, not a diagnosis, and always warrants investigation for an underlying cause.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Hours to days | Stroke, intoxication, Wernicke encephalopathy, post-infectious cerebellitis, medication toxicity | Often represents a medical emergency; rapid identification and treatment essential |
| Subacute | Days to weeks | Paraneoplastic syndrome, vitamin deficiencies, autoimmune cerebellitis, prion disease | High suspicion for treatable or life-threatening conditions; urgent workup required |
| Chronic | Months to years | Hereditary ataxias, multiple sclerosis, chronic alcohol use, degenerative conditions | Genetic testing and systematic evaluation; focus on treatable causes and symptom management |
Classification by Type
Cerebellar Ataxia
Features: Wide-based gait, intention tremor, dysmetria, dysdiadochokinesia, nystagmus, dysarthria (scanning speech)
Key characteristic: Symptoms do NOT significantly worsen with eye closure (Romberg negative)
Sensory Ataxia
Features: “Stomping” gait, positive Romberg sign, loss of proprioception and vibration sense, pseudoathetosis
Key characteristic: Symptoms markedly WORSEN with eye closure (Romberg positive)
Vestibular Ataxia
Features: Unsteadiness with tendency to fall to one side, vertigo, nystagmus, nausea and vomiting
Key characteristic: Associated with prominent vertigo; directional preponderance of falling
Classification by Anatomical Location
| Location | Clinical Features | Associated Findings |
|---|---|---|
| Midline Cerebellar (Vermis) | Truncal ataxia, gait instability, titubation (rhythmic tremor of head and trunk) | Relatively preserved limb coordination; often seen in alcoholic cerebellar degeneration |
| Lateral Cerebellar (Hemispheres) | Appendicular ataxia, limb dysmetria, intention tremor, dysdiadochokinesia | Ipsilateral to lesion; gait may be relatively preserved |
| Pancerebellar | Combined truncal and appendicular ataxia with all cerebellar signs | Suggests diffuse process: toxic, metabolic, paraneoplastic, or hereditary |
| Posterior Column | Sensory ataxia with positive Romberg, preserved strength | Vitamin B12 deficiency, tabes dorsalis, Friedreich ataxia |
| Peripheral Nerve | Sensory ataxia with distal sensory loss in stocking-glove distribution | Large fiber neuropathies: diabetic, inflammatory, paraneoplastic |
Classification by Temporal Pattern
| Pattern | Description | Suggests |
|---|---|---|
| Sudden onset (seconds to minutes) | Ataxia develops abruptly at a definable moment | Vascular event (cerebellar stroke or hemorrhage) — neurosurgical emergency |
| Acute onset (hours to days) | Rapid development over short period | Intoxication, infection, Wernicke encephalopathy, post-infectious cerebellitis |
| Subacute progressive (weeks) | Steady worsening over weeks | Paraneoplastic syndrome, autoimmune cerebellitis, prion disease, vitamin deficiency |
| Chronic progressive (months to years) | Slow insidious progression | Hereditary ataxias, multiple system atrophy, chronic alcohol toxicity |
| Episodic | Recurrent attacks with return to baseline | Episodic ataxias (channelopathies), basilar migraine, metabolic disorders |
| Static (non-progressive) | Present since early life without progression | Congenital malformations, perinatal injury, structural anomalies |
The Three Types: Always determine whether the ataxia is cerebellar, sensory, or vestibular in origin. This fundamental distinction guides the entire diagnostic approach:
- Cerebellar ataxia — Romberg negative, nystagmus, dysarthria, intention tremor
- Sensory ataxia — Romberg positive, proprioceptive loss, preserved speech
- Vestibular ataxia — Vertigo, directional falling, nystagmus with specific characteristics
Clinical Impact
Ataxia significantly impacts quality of life through impaired mobility, increased fall risk, communication difficulties from dysarthria, and loss of independence. Early recognition and treatment of reversible causes (such as vitamin deficiencies, toxins, and autoimmune conditions) can prevent permanent disability. Even in degenerative conditions, symptomatic treatment and rehabilitation can substantially improve function.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of Ataxia
Understanding the pathophysiology of ataxia requires knowledge of the neural systems responsible for coordinated movement. The cerebellum, sensory pathways, and vestibular system each contribute to motor coordination in distinct ways. Dysfunction at any level of these systems produces characteristic patterns of incoordination that can be distinguished clinically. This mechanistic understanding is essential for localizing lesions and directing the diagnostic workup.
The Cerebellum: Master Coordinator
| Cerebellar Region | Anatomical Structure | Function | Dysfunction Produces |
|---|---|---|---|
| Vestibulocerebellum | Flocculonodular lobe | Balance, vestibulo-ocular reflex, eye movement coordination | Truncal ataxia, nystagmus, impaired gaze stability |
| Spinocerebellum | Vermis and paravermal zones | Gait and posture, integration of proprioceptive input | Gait ataxia, postural instability, titubation |
| Cerebrocerebellum | Lateral hemispheres | Planning and coordination of skilled limb movements | Limb dysmetria, intention tremor, dysdiadochokinesia |
Neural Pathways Involved in Coordination
| Pathway | Input Source | Processing | Output/Effect |
|---|---|---|---|
| Spinocerebellar tracts | Proprioceptors in muscles, joints, tendons | Cerebellar cortex integrates with motor commands | Real-time adjustment of ongoing movements |
| Corticopontocerebellar pathway | Motor and premotor cortex via pontine nuclei | Cerebellar hemispheres compare intended vs actual movement | Error correction, movement refinement |
| Vestibulocerebellar pathway | Vestibular nuclei and labyrinth | Flocculonodular lobe processes balance information | Postural adjustments, gaze stabilization |
| Posterior columns | Dorsal root ganglia (proprioception, vibration) | Fasciculus gracilis and cuneatus to thalamus | Conscious proprioception for movement guidance |
| Cerebellar output | Deep cerebellar nuclei | Superior cerebellar peduncle to red nucleus and thalamus | Modulation of motor cortex and brainstem motor centers |
Mechanisms by Ataxia Type
Cerebellar Ataxia
Mechanism: Loss of cerebellar modulation of motor commands
Timing errors: Inability to properly time muscle activation (asynergia)
Force errors: Over- or under-shooting targets (dysmetria)
Why Romberg negative: Vision cannot compensate for cerebellar processing deficits
Sensory Ataxia
Mechanism: Loss of proprioceptive feedback to motor system
Result: Movements made “blind” without position sense
Compensation: Visual guidance partially compensates
Why Romberg positive: Removing visual input eliminates the compensatory mechanism
Vestibular Ataxia
Mechanism: Asymmetric vestibular input creates false sense of motion
Result: Postural responses inappropriate for actual body position
Direction: Tendency to fall toward side of lesion (peripheral) or variable (central)
Why vertigo: Mismatch between vestibular, visual, and proprioceptive inputs
How Conditions Cause Ataxia
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Cerebellar stroke | Ischemia causes neuronal death in specific vascular territories; posterior inferior cerebellar artery (PICA), anterior inferior cerebellar artery (AICA), or superior cerebellar artery (SCA) | Emergency reperfusion if eligible; risk of edema and herniation requiring surgical decompression |
| Alcohol toxicity | Direct Purkinje cell toxicity (primarily vermis); also thiamine deficiency causing Wernicke encephalopathy | Thiamine replacement before glucose; vermis atrophy may be irreversible |
| Paraneoplastic cerebellar degeneration | Antibodies (anti-Yo, anti-Hu, anti-Ri) target cerebellar neurons; immune-mediated Purkinje cell death | Identify and treat underlying malignancy; immunotherapy often ineffective once neuronal loss occurs |
| Vitamin B12 deficiency | Demyelination of posterior columns and peripheral nerves; impaired proprioception | B12 replacement can halt progression; early treatment may allow recovery |
| Multiple sclerosis | Demyelinating plaques in cerebellar peduncles or cerebellar white matter; may also affect sensory pathways | Disease-modifying therapy; symptomatic treatment of tremor challenging |
| Friedreich ataxia | Frataxin deficiency causes mitochondrial iron accumulation; degeneration of spinocerebellar tracts, posterior columns, and dorsal root ganglia | Omaveloxolone (Nrf2 activator) recently approved; supportive care and cardiac monitoring |
| Spinocerebellar ataxias | Polyglutamine repeat expansions or other mutations cause progressive cerebellar and brainstem degeneration | Genetic counseling; symptomatic treatment; clinical trials for disease-modifying therapies |
| Phenytoin toxicity | High levels cause reversible cerebellar dysfunction; chronic use may cause permanent Purkinje cell loss | Check drug levels; dose reduction or discontinuation; irreversible if chronic |
| Anti-GAD antibody syndrome | Antibodies against glutamic acid decarboxylase impair GABAergic neurotransmission in cerebellum | Immunotherapy (steroids, IVIg, rituximab); associated with type 1 diabetes |
| Wernicke encephalopathy | Thiamine deficiency causes lesions in mammillary bodies, medial thalamus, periaqueductal gray, and cerebellar vermis | Medical emergency; high-dose IV thiamine before glucose administration |
Cellular and Molecular Mechanisms
Purkinje Cell Vulnerability
- High metabolic demand: Large neurons with extensive dendritic arbors require substantial energy
- Excitotoxicity: Receive massive glutamatergic input; vulnerable to calcium-mediated injury
- Limited regenerative capacity: Post-mitotic neurons cannot be replaced once lost
- Target of autoantibodies: Express antigens recognized in paraneoplastic syndromes
Common Pathogenic Pathways
- Oxidative stress: Frataxin deficiency, mitochondrial disorders
- Protein aggregation: Polyglutamine expansions in spinocerebellar ataxias
- Channelopathies: Episodic ataxias from calcium or potassium channel mutations
- Immune-mediated: Antibody-mediated or T-cell mediated cerebellar injury
Often Overlooked Mechanism
Cerebellar cognitive affective syndrome: The cerebellum is not only a motor structure. Damage to the posterior lobe and vermis can cause executive dysfunction, spatial cognition deficits, personality changes, and language difficulties. Patients with cerebellar lesions may have subtle cognitive and affective symptoms that are often attributed to other causes. Always assess for neuropsychiatric manifestations in patients with cerebellar disease.
Compensatory Mechanisms
The nervous system has remarkable ability to compensate for certain forms of ataxia:
- Visual compensation: Sensory ataxia patients learn to rely heavily on visual feedback — this is why they worsen with eye closure
- Central vestibular compensation: Peripheral vestibular lesions often improve over weeks as brainstem recalibrates
- Motor learning: Intensive rehabilitation can partially compensate for cerebellar dysfunction through cortical motor learning
- Cerebellar reserve: Slowly progressive lesions may remain subclinical until reserve is exhausted
3. History Taking
A comprehensive approach to eliciting the Ataxia history
Red Flags — Require Urgent Evaluation
- Sudden onset (minutes) — Cerebellar stroke or hemorrhage; neurosurgical emergency
- Severe headache with ataxia — Cerebellar hemorrhage, mass with raised intracranial pressure
- Decreased consciousness — Brainstem compression, Wernicke encephalopathy, intoxication
- New cranial nerve deficits — Brainstem involvement, increased intracranial pressure
- Rapidly progressive (days to weeks) — Paraneoplastic syndrome, prion disease, autoimmune cerebellitis
- Associated with confusion and ophthalmoplegia — Wernicke encephalopathy; give thiamine immediately
- Recent or current malignancy — Paraneoplastic cerebellar degeneration; brain metastases
- Fever with ataxia — Infectious cerebellitis, meningoencephalitis, brain abscess
Systematic History: The “BALANCE” Approach
Use the mnemonic “BALANCE” to ensure comprehensive history taking for ataxia:
- B — Beginning and course: When did it start? Sudden, acute, subacute, or chronic? Getting better, worse, or stable? Episodic or continuous?
- A — Associated symptoms: Vertigo? Diplopia? Dysarthria? Dysphagia? Weakness? Numbness? Cognitive changes? Headache?
- L — Limbs and trunk: Which parts affected? Arms, legs, or trunk? One side or both? Does gait worsen in darkness?
- A — Alcohol and toxins: Alcohol use (quantity, duration)? Medications (anticonvulsants, lithium, sedatives)? Recreational drugs? Occupational exposures?
- N — Nutritional and medical history: Diet and nutritional status? Diabetes? Thyroid disease? Celiac disease? Malignancy history? Autoimmune conditions?
- C — Congenital and family: Similar symptoms in family members? Consanguinity? Age of onset of symptoms in relatives? Known genetic conditions?
- E — Eye closure effect: Does unsteadiness worsen significantly with eyes closed? Critical for distinguishing sensory from cerebellar ataxia
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Cerebellar stroke | Sudden onset, vascular risk factors, headache, vertigo | “Can you tell me exactly what you were doing when this started? Did it come on suddenly or gradually?” |
| Wernicke encephalopathy | Alcohol use, malnutrition, confusion, eye movement abnormalities | “How much alcohol do you drink? Have you been eating regularly? Have you noticed any confusion or double vision?” |
| Medication toxicity | Dose change, new medication, known cerebellar toxins | “Have any of your medications been changed recently? Are you taking phenytoin, carbamazepine, lithium, or any sedatives?” |
| Paraneoplastic syndrome | Subacute onset, smoking history, weight loss, known malignancy | “Have you lost weight recently? Do you smoke? Have you ever been diagnosed with cancer? Any new lumps or night sweats?” |
| Multiple sclerosis | Young adult, relapsing symptoms, sensory symptoms, prior episodes | “Have you had previous episodes of neurological symptoms that came and went? Any vision problems, numbness, or weakness in the past?” |
| Vitamin B12 deficiency | Sensory symptoms, vegetarian diet, gastric surgery, elderly | “Do you have numbness or tingling in your feet? Are you vegetarian or vegan? Have you had stomach surgery?” |
| Hereditary ataxia | Chronic progressive, family history, childhood or young adult onset | “Does anyone in your family have difficulty walking or balance problems? Were your parents related before marriage?” |
| Vestibular disorder | Vertigo, nausea, hearing symptoms, positional component | “Do you feel the room is spinning? Is it worse when you move your head or change position? Any hearing loss or ringing in your ears?” |
| Episodic ataxia | Recurrent attacks, triggers, family history, interictal normalcy | “Do the episodes come and go? Are you completely normal between attacks? Does stress, fatigue, or caffeine trigger episodes?” |
| Autoimmune cerebellitis | Subacute, associated autoimmune conditions, anti-GAD antibodies | “Do you have diabetes, thyroid disease, or any autoimmune conditions? Have you had any recent infections?” |
Medication and Toxin History
Medications That Cause Ataxia
- Anticonvulsants — Phenytoin (most common), carbamazepine, phenobarbital, gabapentin at high doses
- Lithium — Dose-dependent toxicity; may cause permanent cerebellar damage
- Benzodiazepines — Sedation and cerebellar suppression; usually reversible
- Aminoglycosides — Vestibulotoxicity causing vestibular ataxia
- Chemotherapy — Cytarabine, 5-fluorouracil, methotrexate can cause cerebellar toxicity
- Metronidazole — Prolonged use can cause cerebellar syndrome
- Amiodarone — Rare but recognized cause of cerebellar dysfunction
Social and Environmental History
- Alcohol: Quantify intake (drinks per day/week); duration of heavy use; periods of abstinence; nutritional status
- Recreational drugs: Cannabis, synthetic cannabinoids, ketamine, inhalants
- Occupational exposure: Heavy metals (mercury, lead, thallium), organic solvents, pesticides
- Diet: Vegetarian/vegan status (B12 risk); gluten intake if celiac suspected; eating disorders
- Travel: Endemic areas for infectious causes (viral cerebellitis, parasites)
Establishing the Temporal Profile
Critical Temporal Questions
The temporal profile is the single most important historical feature for narrowing the differential diagnosis:
- “When exactly did this start?” — Distinguish seconds/minutes (vascular) from hours/days (toxic, infectious) from weeks (paraneoplastic, autoimmune) from months/years (degenerative, hereditary)
- “What were you doing when it began?” — Activity at onset may suggest mechanism (exertion → dissection, vascular)
- “Has it been getting worse, better, or staying the same?” — Progressive suggests degenerative or ongoing toxic exposure; improving suggests post-infectious or resolving toxic cause
- “Does it come and go, or is it constant?” — Episodic pattern suggests channelopathy, migraine, or metabolic disorder
- “Is there anything that makes it better or worse?” — Eye closure worsening (sensory); position change (vestibular); triggers (episodic ataxia)
Family History: Key Points
| Finding | Suggests | Follow-up Questions |
|---|---|---|
| Affected parent | Autosomal dominant spinocerebellar ataxia | Age of onset in parent? Which symptoms first? Anticipation (earlier onset in successive generations)? |
| Affected siblings only | Autosomal recessive ataxia (Friedreich ataxia, ataxia-telangiectasia) | Consanguinity? Other recessive conditions in family? |
| Maternal inheritance pattern | Mitochondrial disorder | Other maternal relatives affected? Diabetes, hearing loss, myopathy in family? |
| No family history but early onset | De novo mutation, recessive condition, or acquired cause | Detailed three-generation pedigree; consider genetic testing |
4. Physical Examination
A systematic neurological approach for Ataxia
Systematic Framework: Use a structured neurological examination to: (1) confirm the presence of ataxia, (2) distinguish cerebellar from sensory from vestibular ataxia, (3) localize the lesion within the nervous system, and (4) identify associated findings that narrow the differential diagnosis.
General Inspection
- Nutritional status: Cachexia suggests malignancy or chronic alcohol use; obesity may suggest hypothyroidism
- Skin examination: Telangiectasias (ataxia-telangiectasia); xanthomas (cerebrotendinous xanthomatosis); café-au-lait spots (neurofibromatosis)
- Skeletal abnormalities: Scoliosis and pes cavus (Friedreich ataxia); kyphosis
- Spontaneous movements: Titubation (rhythmic head/trunk tremor); myoclonus; dystonia
- Mental status: Confusion (Wernicke encephalopathy, paraneoplastic); cognitive slowing (hereditary ataxias)
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Blood Pressure | Hypertension; orthostatic hypotension | Severe hypertension suggests cerebellar hemorrhage; orthostatic hypotension in multiple system atrophy |
| Heart Rate | Tachycardia; irregular rhythm | Atrial fibrillation is risk factor for cerebellar embolism; tachycardia in thyrotoxicosis or Wernicke |
| Temperature | Fever | Infectious cerebellitis, meningoencephalitis, brain abscess |
| Respiratory Rate | Abnormal breathing patterns | Irregular breathing may indicate brainstem involvement |
Eye and Cranial Nerve Examination
Ocular Movements — Critical for Localization
| Finding | Description | Localization/Diagnosis |
|---|---|---|
| Gaze-evoked nystagmus | Nystagmus appearing on lateral or vertical gaze; fast phase toward direction of gaze | Cerebellar dysfunction; medication toxicity (phenytoin, alcohol) |
| Downbeat nystagmus | Fast phase beating downward, worse on lateral downgaze | Craniocervical junction pathology (Chiari malformation, foramen magnum lesions) |
| Periodic alternating nystagmus | Horizontal nystagmus that reverses direction every 90-120 seconds | Cerebellar nodulus lesion; responds to baclofen |
| Saccadic dysmetria | Overshooting (hypermetria) or undershooting (hypometria) of target | Cerebellar hemisphere or vermis dysfunction |
| Impaired smooth pursuit | Jerky, saccadic pursuit movements instead of smooth tracking | Cerebellar flocculus; widespread cerebellar disease |
| Ocular flutter/opsoclonus | Involuntary rapid conjugate saccades (horizontal or multidirectional) | Paraneoplastic syndrome; post-infectious; brainstem encephalitis |
| Internuclear ophthalmoplegia | Impaired adduction with nystagmus of abducting eye | Multiple sclerosis; brainstem stroke |
| Ophthalmoplegia with ataxia | Limited eye movements in multiple directions | Wernicke encephalopathy (lateral rectus palsy common); Miller Fisher syndrome |
Other Cranial Nerve Findings
- Facial weakness: May accompany pontine or cerebellopontine angle lesions
- Hearing loss: Acoustic neuroma; aminoglycoside toxicity; superficial siderosis
- Bulbar signs: Dysarthria and dysphagia suggest brainstem involvement (multiple system atrophy, spinocerebellar ataxia)
- Absent corneal reflex: Cerebellopontine angle tumor
Cerebellar Examination
Gait Assessment
| Test | Technique | Abnormal Finding | Interpretation |
|---|---|---|---|
| Observation of gait | Ask patient to walk across the room, turn, and return | Wide-based, lurching, irregular steps; difficulty with turns | Cerebellar gait ataxia |
| Tandem gait | Walk heel-to-toe in a straight line | Unable to perform; veering; excessive sway | Sensitive test for mild cerebellar dysfunction |
| Romberg test | Stand with feet together, arms at sides; observe with eyes open, then closed | Falls or marked increase in sway with eye closure | POSITIVE = sensory ataxia; NEGATIVE = cerebellar ataxia |
| Walking with eyes closed | Walk forward with eyes closed (ensure safety) | Marked deviation or inability to walk | Sensory ataxia worsens; cerebellar ataxia relatively unchanged |
Upper Limb Coordination
| Test | Technique | Abnormal Finding | Interpretation |
|---|---|---|---|
| Finger-nose-finger test | Touch examiner’s finger, then own nose, repeatedly; examiner moves target | Intention tremor; past-pointing (dysmetria); decomposition of movement | Cerebellar hemisphere dysfunction (ipsilateral to lesion) |
| Rapid alternating movements | Rapidly pronate/supinate hands on thighs; finger tapping | Irregular rhythm and amplitude (dysdiadochokinesia) | Cerebellar dysfunction; distinguish from bradykinesia (Parkinson) |
| Rebound test | Patient flexes arm against resistance; examiner suddenly releases | Arm swings excessively; unable to check movement | Loss of cerebellar checking function |
| Drawing spirals | Draw an Archimedes spiral | Irregular, tremulous lines; spiral disintegration | Cerebellar dysfunction; useful for monitoring progression |
Lower Limb Coordination
- Heel-shin test: Run heel smoothly down opposite shin from knee to ankle; abnormal if side-to-side oscillation or inability to maintain contact
- Toe-finger test: Touch examiner’s finger with great toe; assess for dysmetria
- Foot tapping: Tap foot rapidly on floor; assess for irregular rhythm
Speech Assessment
- Scanning dysarthria: Speech broken into syllables with irregular emphasis (“scanning” or “staccato” quality)
- Slurred speech: May also reflect brainstem involvement or intoxication
- Test phrases: “British constitution,” “hippopotamus,” “Methodist Episcopal”
Sensory Examination — Essential for Sensory Ataxia
| Modality | Pathway | How to Test | Significance if Abnormal |
|---|---|---|---|
| Vibration sense | Posterior columns | 128 Hz tuning fork on bony prominences (medial malleolus, tibial tuberosity, iliac crest) | Loss indicates posterior column dysfunction; B12 deficiency, tabes dorsalis, Friedreich ataxia |
| Joint position sense | Posterior columns | Hold sides of distal phalanx; move up or down; patient identifies direction with eyes closed | Loss causes sensory ataxia; test increasingly proximal joints if impaired distally |
| Romberg test | Integrates proprioception | As described above | Positive Romberg = sensory ataxia |
| Pseudoathetosis | Loss of proprioception | Observe outstretched hands with eyes closed | Involuntary writhing movements of fingers = severe proprioceptive loss |
Vestibular Examination
Bedside Tests
- Head impulse test (HIT): Rapid head rotation while patient fixates on examiner’s nose; corrective saccade indicates peripheral vestibular lesion
- Dix-Hallpike maneuver: Provokes nystagmus in benign paroxysmal positional vertigo
- Nystagmus characteristics: Direction-fixed (peripheral) vs direction-changing (central)
- Skew deviation: Vertical misalignment suggests central lesion
HINTS Examination (for Acute Vestibular Syndrome)
- Head Impulse — Normal in central lesions
- Nystagmus — Direction-changing suggests central cause
- Test of Skew — Skew deviation suggests central cause
- Clinical pearl: HINTS more sensitive than early MRI for cerebellar stroke
Reflexes and Motor Examination
| Finding | Pattern | Suggests |
|---|---|---|
| Hyporeflexia with extensor plantar responses | Absent ankle jerks + upgoing toes | Friedreich ataxia; B12 deficiency (combined degeneration) |
| Generalized hyporeflexia | All reflexes diminished or absent | Peripheral neuropathy; Miller Fisher syndrome; sensory neuronopathy |
| Hyperreflexia | Brisk reflexes with spasticity | Multiple sclerosis; spinocerebellar ataxias with pyramidal involvement |
| Pendular reflexes | Knee jerk swings back and forth before settling | Cerebellar hypotonia |
| Weakness pattern | Pyramidal distribution | Associated corticospinal tract involvement (many spinocerebellar ataxias) |
Expected Findings by Etiology
| Condition | Gait and Coordination | Eye Findings | Other Key Findings |
|---|---|---|---|
| Alcoholic cerebellar degeneration | Predominantly gait ataxia; legs > arms; truncal instability | Gaze-evoked nystagmus; may have Wernicke features | Peripheral neuropathy; nutritional deficiency signs |
| Cerebellar stroke (PICA territory) | Ipsilateral limb and gait ataxia; sudden onset | Nystagmus; ipsilateral Horner syndrome possible | Headache; vertigo; nausea; may have lateral medullary signs |
| Multiple sclerosis | Variable; may be asymmetric; intention tremor | Internuclear ophthalmoplegia; optic disc pallor; nystagmus | Upper motor neuron signs; sensory level; Lhermitte sign |
| Friedreich ataxia | Progressive gait ataxia; sensory > cerebellar features | Square wave jerks; impaired smooth pursuit | Scoliosis; pes cavus; absent ankle jerks; upgoing toes; cardiomyopathy |
| Vitamin B12 deficiency | Sensory ataxia; positive Romberg; stamping gait | Usually normal; optic neuropathy possible | Loss of vibration/position sense; peripheral neuropathy; cognitive changes |
| Paraneoplastic cerebellar degeneration | Severe pancerebellar ataxia; rapid progression | Severe nystagmus; opsoclonus possible | May have signs of underlying malignancy; often precedes cancer diagnosis |
| Multiple system atrophy (cerebellar type) | Progressive cerebellar ataxia; parkinsonian features | Impaired smooth pursuit; gaze-evoked nystagmus | Autonomic failure (orthostatic hypotension, urinary symptoms); pyramidal signs |
Important Teaching Point
The Romberg test is the key discriminator:
- Romberg NEGATIVE (no significant worsening with eye closure) = Cerebellar ataxia — visual input cannot compensate for cerebellar dysfunction
- Romberg POSITIVE (marked worsening with eye closure) = Sensory ataxia — patient relies on vision to compensate for lost proprioception
Note: Some patients have both cerebellar and sensory components (e.g., Friedreich ataxia), making interpretation more nuanced. Also, severe cerebellar ataxia may show some worsening with eye closure, but not the dramatic change seen in pure sensory ataxia.
5. Differential Diagnosis
Systematic approach organized by temporal profile and probability
Acute Ataxia (Hours to Days)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON | Alcohol intoxication | History of alcohol use; altered consciousness; smell of alcohol; reversible | Concurrent head trauma; altered mental status out of proportion to intake |
| COMMON | Medication toxicity | Recent dose increase or new medication; phenytoin, carbamazepine, lithium, benzodiazepines | Supratherapeutic drug levels; polypharmacy in elderly |
| COMMON | Benign paroxysmal positional vertigo | Brief episodes triggered by position change; positive Dix-Hallpike; vestibular ataxia | Persistent symptoms; central nystagmus features |
| LESS COMMON | Cerebellar stroke (ischemic) | Sudden onset; vascular risk factors; headache; vertigo; nausea | Decreased consciousness; severe headache; cranial nerve deficits |
| LESS COMMON | Wernicke encephalopathy | Triad: ataxia, confusion, ophthalmoplegia; malnutrition; alcohol use | Medical emergency; give thiamine before glucose |
| LESS COMMON | Vestibular neuritis | Acute vertigo with vestibular ataxia; recent viral illness; positive head impulse test | Normal HINTS exam suggests central cause |
| UNCOMMON BUT SERIOUS | Cerebellar hemorrhage | Sudden severe headache; hypertension; rapid deterioration | Neurosurgical emergency; risk of herniation |
| UNCOMMON BUT SERIOUS | Basilar artery occlusion | Decreased consciousness; bilateral signs; cranial nerve palsies | High mortality; requires urgent intervention |
| UNCOMMON BUT SERIOUS | Post-infectious cerebellitis | Following viral illness (varicella, EBV); more common in children but occurs in adults | Usually self-limiting but may be severe |
| UNCOMMON BUT SERIOUS | Miller Fisher syndrome | Ataxia, areflexia, ophthalmoplegia; recent infection; anti-GQ1b antibodies | May progress to Guillain-Barré syndrome |
Subacute Ataxia (Days to Weeks)
High-Yield Alert
Subacute progressive ataxia is a neurological emergency until proven otherwise. The differential includes several treatable conditions (vitamin deficiencies, autoimmune) and conditions where early diagnosis affects prognosis (paraneoplastic syndrome — find the cancer; prion disease — infection control).
| Probability | Condition | Key Features | Urgent Action |
|---|---|---|---|
| CONSIDER FIRST | Paraneoplastic cerebellar degeneration | Subacute progressive; may precede cancer diagnosis by months; anti-Yo, anti-Hu, anti-Ri antibodies | Paraneoplastic antibody panel; CT chest/abdomen/pelvis; mammogram; PET scan |
| CONSIDER FIRST | Autoimmune cerebellitis (anti-GAD, others) | May have associated type 1 diabetes or thyroid disease; subacute onset; treatable | Anti-GAD antibodies; comprehensive autoimmune panel; trial of immunotherapy |
| CONSIDER FIRST | Vitamin deficiencies (B12, E, B1) | Nutritional risk factors; sensory symptoms; treatable if caught early | Check B12, folate, vitamin E, thiamine levels; treat empirically if clinical suspicion |
| LESS COMMON | Creutzfeldt-Jakob disease (prion) | Rapidly progressive dementia with ataxia; myoclonus; characteristic MRI and EEG | MRI (DWI); EEG; CSF 14-3-3 protein and RT-QuIC |
| LESS COMMON | CNS lymphoma | Immunocompromised patients; may have multifocal lesions; may respond to steroids initially | MRI with contrast; CSF cytology; stereotactic biopsy |
| LESS COMMON | Progressive multifocal leukoencephalopathy | Immunocompromised; JC virus; multifocal white matter lesions | MRI; CSF JC virus PCR; check HIV status |
| LESS COMMON | Chronic meningitis (TB, fungal, carcinomatous) | Headache; cranial neuropathies; CSF abnormalities | LP with comprehensive studies; consider meningeal biopsy |
Chronic Ataxia (Months to Years)
Step-by-Step Approach to Chronic Ataxia:
- Step 1: Rule out acquired treatable causes — vitamin deficiencies, hypothyroidism, celiac disease, chronic alcohol use
- Step 2: Determine if cerebellar, sensory, or mixed ataxia — guides further testing
- Step 3: Assess family history — positive family history suggests hereditary ataxia; obtain genetic testing
- Step 4: Consider sporadic degenerative conditions — multiple system atrophy if autonomic features; idiopathic late-onset cerebellar ataxia
- Step 5: Investigate for occult causes — anti-GAD antibodies, gluten sensitivity, paraneoplastic (may present insidiously)
| Category | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| ACQUIRED — COMMON | Alcoholic cerebellar degeneration | Most common acquired cause | Gait > limb ataxia; vermis atrophy on MRI; history of heavy alcohol use |
| ACQUIRED — COMMON | Multiple sclerosis | Common in MS patients | Relapsing-remitting course; white matter lesions; other neurological symptoms |
| ACQUIRED — LESS COMMON | Chronic phenytoin toxicity | Variable | Long-term anticonvulsant use; may be irreversible |
| ACQUIRED — LESS COMMON | Gluten ataxia | Up to 15% of idiopathic ataxias | Anti-gliadin antibodies; may not have GI symptoms; responds to gluten-free diet |
| ACQUIRED — LESS COMMON | Superficial siderosis | Rare | Hearing loss; ataxia; myelopathy; hemosiderin on MRI; history of CNS bleeding |
| HEREDITARY — AUTOSOMAL RECESSIVE | Friedreich ataxia | Most common hereditary ataxia | Onset before age 25; cardiomyopathy; scoliosis; pes cavus; diabetes |
| HEREDITARY — AUTOSOMAL RECESSIVE | Ataxia-telangiectasia | Second most common in children | Oculocutaneous telangiectasias; immunodeficiency; elevated AFP; cancer risk |
| HEREDITARY — AUTOSOMAL DOMINANT | Spinocerebellar ataxias (SCAs) | Over 40 types identified | Positive family history; variable phenotypes; genetic testing available for common types |
| HEREDITARY — AUTOSOMAL DOMINANT | Episodic ataxias (EA1, EA2) | Rare | Attacks triggered by stress, exertion; interictal nystagmus (EA2); responds to acetazolamide |
| SPORADIC DEGENERATIVE | Multiple system atrophy — cerebellar type | Common sporadic cause in older adults | Autonomic failure; parkinsonism; poor levodopa response; “hot cross bun” sign on MRI |
| SPORADIC DEGENERATIVE | Idiopathic late-onset cerebellar ataxia | Diagnosis of exclusion | Onset after age 50; no family history; negative workup; slowly progressive |
Anatomical Approach to Ataxia
Cerebellar — Midline (Vermis)
Alcoholic cerebellar degeneration
Medulloblastoma
Wernicke encephalopathy
Paraneoplastic (anti-Yo)
Features: Gait > limb ataxia; truncal instability
Cerebellar — Hemisphere
Cerebellar stroke (PICA, AICA, SCA)
Cerebellar hemorrhage
Tumor or metastasis
Multiple sclerosis plaque
Features: Ipsilateral limb ataxia; dysmetria
Sensory Pathways
Vitamin B12 deficiency
Vitamin E deficiency
Tabes dorsalis (neurosyphilis)
Sensory neuronopathy (paraneoplastic, Sjögren)
Features: Romberg positive; proprioceptive loss
Mixed Cerebellar and Sensory
Friedreich ataxia
Spinocerebellar ataxias (some types)
Multiple sclerosis
Superficial siderosis
Features: Combined findings; variable Romberg
Drug-Induced Ataxia
| Drug or Drug Class | Mechanism | Characteristics | Resolution After Stopping |
|---|---|---|---|
| Phenytoin | Direct Purkinje cell toxicity; dose-dependent and chronic effects | Nystagmus often first sign; gait ataxia; dysarthria at higher levels | Acute: days; Chronic use: may be permanent |
| Carbamazepine | Cerebellar suppression; usually dose-related | Similar to phenytoin; often with diplopia and dizziness | Usually reversible within days to weeks |
| Lithium | Cerebellar toxicity; may cause permanent damage | Tremor, ataxia, cognitive changes; may persist after normalization of levels | Variable; permanent damage possible |
| Benzodiazepines | GABAergic enhancement; cerebellar suppression | Sedation; slurred speech; unsteady gait; elderly more susceptible | Reversible; depends on half-life of drug |
| Aminoglycosides | Vestibulotoxicity; hair cell damage | Vestibular ataxia; oscillopsia; bilateral vestibular loss | Often permanent; partial compensation over months |
| Cytarabine (high-dose) | Direct cerebellar toxicity | Occurs during or after treatment; may be severe | Variable; may be permanent |
| 5-Fluorouracil | Cerebellar toxicity; dihydropyrimidine dehydrogenase deficiency increases risk | Acute cerebellar syndrome during treatment | Usually reversible if recognized early |
| Metronidazole | Cerebellar and peripheral nerve toxicity with prolonged use | Sensory neuropathy and cerebellar signs; MRI may show lesions | Usually reversible over weeks to months |
| Alcohol (acute) | Cerebellar suppression; GABAergic effects | Dose-dependent; reversible with metabolism | Hours (depends on amount consumed) |
| Alcohol (chronic) | Direct toxicity + thiamine deficiency; vermis degeneration | Predominantly gait ataxia; may have peripheral neuropathy | Often permanent; some improvement with abstinence |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Sudden onset + headache + vomiting | Cerebellar hemorrhage or stroke | Emergent CT head; neurosurgery consult |
| Ataxia + confusion + ophthalmoplegia | Wernicke encephalopathy | IV thiamine immediately (before glucose) |
| Ataxia + areflexia + ophthalmoplegia | Miller Fisher syndrome | Anti-GQ1b antibodies; monitor for respiratory involvement |
| Subacute ataxia + smoking history | Paraneoplastic cerebellar degeneration | Paraneoplastic panel; CT chest; PET scan |
| Ataxia + rapid dementia + myoclonus | Creutzfeldt-Jakob disease | MRI (DWI); EEG; CSF RT-QuIC |
| Positive Romberg + absent ankle jerks + upgoing toes | Friedreich ataxia or B12 deficiency | B12 level; frataxin gene testing |
| Ataxia + pes cavus + scoliosis + cardiomyopathy | Friedreich ataxia | Genetic testing for GAA repeat expansion |
| Ataxia + telangiectasias + recurrent infections | Ataxia-telangiectasia | AFP level; ATM gene testing; immunoglobulin levels |
| Ataxia + autonomic failure + parkinsonism | Multiple system atrophy | MRI (hot cross bun sign); autonomic function tests |
| Ataxia + downbeat nystagmus | Craniocervical junction pathology (Chiari malformation) | MRI of craniocervical junction |
| Episodic ataxia + migraine + positive family history | Episodic ataxia type 2 | CACNA1A gene testing; trial of acetazolamide |
| Ataxia + hearing loss + bilateral vestibular loss | Superficial siderosis or aminoglycoside toxicity | MRI with gradient echo sequences; medication history |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Unexplained Ataxia
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| MRI brain with contrast | Identify structural lesions, atrophy pattern, white matter disease | Cerebellar atrophy; stroke; tumor; demyelination; “hot cross bun” sign | Essential first-line imaging; CT only if MRI contraindicated or for emergent hemorrhage |
| Complete blood count | Screen for macrocytic anemia (B12 deficiency), infection | Macrocytosis; anemia; elevated WBC | Macrocytosis may precede B12 deficiency symptoms |
| Comprehensive metabolic panel | Electrolytes, renal function, liver function, glucose | Hyponatremia; uremia; hepatic encephalopathy; diabetes | Baseline for medication dosing; identify metabolic causes |
| Vitamin B12 level | Identify B12 deficiency (treatable cause) | Low B12; consider methylmalonic acid if borderline | Treat if low-normal with symptoms; methylmalonic acid more sensitive |
| Thyroid function tests | Screen for hypothyroidism (associated with ataxia) | Elevated TSH; low T4 | Hypothyroidism can cause cerebellar dysfunction |
| Vitamin E level | Identify vitamin E deficiency (especially if malabsorption) | Low vitamin E level | Consider in patients with fat malabsorption, cholestatic liver disease |
| Anticonvulsant drug levels | Identify drug toxicity if on phenytoin, carbamazepine | Supratherapeutic levels | Chronic therapeutic levels can still cause cerebellar toxicity |
| RPR or VDRL | Screen for neurosyphilis (tabes dorsalis) | Positive serology | If positive, obtain FTA-ABS and lumbar puncture |
Targeted Investigations by Suspected Etiology
If Suspecting Paraneoplastic Cerebellar Degeneration
First-Line Tests
- Paraneoplastic antibody panel: Anti-Yo (ovarian, breast); Anti-Hu (small cell lung); Anti-Ri (breast, lung); Anti-CV2/CRMP5; Anti-Tr (Hodgkin lymphoma)
- CT chest, abdomen, pelvis: Screen for occult malignancy
- Mammogram: In women (anti-Yo associated with breast cancer)
Second-Line Tests
- PET-CT: If conventional imaging negative but high clinical suspicion
- Testicular ultrasound: In men with anti-Ma2 antibodies
- CSF analysis: May show lymphocytic pleocytosis, elevated protein, oligoclonal bands
- Repeat imaging: Every 3-6 months if antibody positive but no cancer found
If Suspecting Autoimmune Cerebellitis
First-Line Tests
- Anti-GAD65 antibodies: High titers (>10,000 U/mL) associated with cerebellar ataxia
- Anti-thyroid antibodies: Hashimoto encephalopathy can present with ataxia
- Anti-gliadin and anti-tissue transglutaminase antibodies: Gluten ataxia
Second-Line Tests
- CSF analysis: Oligoclonal bands, elevated IgG index
- Anti-CASPR2, anti-LGI1: Voltage-gated potassium channel complex antibodies
- HLA-DQ2/DQ8 testing: If gluten ataxia suspected
- Small bowel biopsy: If celiac disease suspected (may have ataxia without GI symptoms)
If Suspecting Hereditary Ataxia
Initial Approach
- Detailed family pedigree: Three generations; identify inheritance pattern
- Friedreich ataxia testing: GAA repeat expansion in FXN gene (if onset <25 years, recessive pattern)
- SCA panel: Common types (SCA1, 2, 3, 6, 7) if autosomal dominant pattern
Extended Testing
- Ataxia gene panel: Next-generation sequencing panel covering multiple ataxia genes
- Whole exome sequencing: If targeted testing negative
- AFP level: Elevated in ataxia-telangiectasia
- Cholestanol level: Cerebrotendinous xanthomatosis
- White blood cell enzyme assays: If storage disorder suspected
If Suspecting Multiple System Atrophy
First-Line Tests
- MRI brain: “Hot cross bun” sign in pons; putaminal rim sign; cerebellar atrophy
- Autonomic function tests: Tilt-table testing; thermoregulatory sweat test
- Urodynamic studies: Early urinary dysfunction common
Supportive Tests
- Cardiac MIBG scan: Normal in MSA (abnormal in Parkinson disease)
- Sleep study: REM sleep behavior disorder; stridor
- Sphincter EMG: Denervation pattern
If Suspecting Infectious or Inflammatory Cause
| Condition | Key Tests | Expected Findings |
|---|---|---|
| Viral cerebellitis | CSF analysis; viral PCR panel | Lymphocytic pleocytosis; positive viral PCR (VZV, EBV, HSV) |
| Creutzfeldt-Jakob disease | MRI (DWI); EEG; CSF 14-3-3 protein; RT-QuIC | Cortical ribboning on DWI; periodic sharp waves on EEG; positive RT-QuIC (highly specific) |
| Progressive multifocal leukoencephalopathy | MRI brain; CSF JC virus PCR; HIV testing | Multifocal white matter lesions; positive JC virus PCR |
| Whipple disease | Small bowel biopsy; CSF PCR for Tropheryma whipplei | PAS-positive macrophages; positive PCR |
| Neurosyphilis | Serum RPR/VDRL, FTA-ABS; CSF VDRL | Positive serology; CSF pleocytosis; positive CSF VDRL (specific but insensitive) |
When to Perform Lumbar Puncture
Indications for CSF Analysis in Ataxia
- Subacute progressive ataxia: To evaluate for inflammatory, infectious, or neoplastic causes
- Suspected autoimmune cerebellitis: Oligoclonal bands, elevated IgG index
- Suspected infection: Meningitis, encephalitis, Whipple disease
- Suspected Creutzfeldt-Jakob disease: 14-3-3 protein, RT-QuIC assay
- Suspected paraneoplastic syndrome: Pleocytosis, elevated protein
- Suspected multiple sclerosis: Oligoclonal bands
- Suspected neurosyphilis: CSF VDRL
Ensure imaging first: Rule out mass lesion or obstructive hydrocephalus before LP
Empiric Treatment Trials as Diagnostic Tools
Therapeutic Trials in Ataxia
In some cases, empiric treatment can serve as a diagnostic tool. Response to therapy supports the diagnosis:
- Thiamine trial: High-dose IV thiamine (500 mg three times daily for 3 days) if any suspicion of Wernicke encephalopathy — treat before confirming diagnosis
- B12 replacement: If B12 low-normal with symptoms; improvement supports deficiency diagnosis
- Gluten-free diet: Strict adherence for 6-12 months if anti-gliadin antibodies positive; improvement supports gluten ataxia
- Acetazolamide trial: In suspected episodic ataxia type 2; dramatic response supports diagnosis
- Immunotherapy trial: In suspected autoimmune cerebellitis (steroids, IVIg); improvement suggests immune-mediated cause
- Discontinue suspected medication: If drug-induced ataxia suspected; improvement after drug withdrawal (may take weeks for some agents)
Investigation Algorithm by Clinical Scenario
| Clinical Scenario | Essential Investigations | If Initial Workup Negative |
|---|---|---|
| Acute ataxia with headache | Emergent CT head → MRI if CT negative; check glucose, drug levels | Consider LP; toxicology screen; MRA if vascular suspected |
| Subacute progressive (weeks) | MRI brain; paraneoplastic panel; B12, vitamin E; anti-GAD; CT chest/abdomen/pelvis | LP; PET-CT; consider prion testing if dementia present |
| Chronic with positive family history | MRI brain; genetic testing based on inheritance pattern (Friedreich ataxia vs SCA panel) | Extended genetic panel; whole exome sequencing |
| Chronic sporadic onset >50 years | MRI brain; B12; thyroid; anti-gliadin; paraneoplastic panel; autonomic testing | Consider genetic testing (late-onset hereditary); LP; repeat cancer screening |
| Episodic ataxia | MRI brain; EEG; genetic testing (CACNA1A, KCNA1); metabolic workup during attack | Video EEG monitoring; trial of acetazolamide |
| Sensory ataxia (positive Romberg) | B12, vitamin E; nerve conduction studies; MRI spine; syphilis serology | Paraneoplastic panel; Sjögren antibodies; LP; sensory nerve biopsy |
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Sudden onset ataxia with severe headache, vomiting, or decreased consciousness | EMERGENT | Immediate CT head; neurosurgery consult; prepare for possible decompression |
| Ataxia with confusion and ophthalmoplegia (Wernicke triad) | EMERGENT | IV thiamine 500 mg immediately BEFORE glucose; do not wait for labs |
| Acute ataxia with cranial nerve deficits or bilateral signs | EMERGENT | Suspect basilar artery occlusion; emergent CT/CTA; stroke team activation |
| Ataxia with areflexia and recent infection | URGENT | Suspect Miller Fisher syndrome; check respiratory function; anti-GQ1b antibodies; prepare for possible IVIg |
| Subacute progressive ataxia (days to weeks) | URGENT | Admit for expedited workup; paraneoplastic panel; MRI; consider empiric thiamine |
| Acute vertigo with ataxia — need to distinguish central from peripheral | URGENT | Perform HINTS examination; if central pattern, emergent MRI/MRA |
| Chronic progressive ataxia without red flags | ROUTINE | Outpatient neurology referral; systematic workup over weeks |
| Known hereditary ataxia with stable symptoms | ROUTINE | Scheduled follow-up; rehabilitation; genetic counseling |
Step 2: Classify by Duration
Acute (Hours to Days)
Proceed to Algorithm A
Focus on: Vascular, toxic, infectious causes
Key questions: Sudden or gradual? Medications? Alcohol? Fever?
Subacute (Days to Weeks)
Proceed to Algorithm B
Focus on: Paraneoplastic, autoimmune, vitamin deficiency, prion
Key questions: Cancer history? Smoking? Weight loss? Rapid progression?
Chronic (Months to Years)
Proceed to Algorithm C
Focus on: Hereditary, degenerative, chronic toxic
Key questions: Family history? Age of onset? Associated features?
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Ataxia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Sudden onset + severe headache + hypertension | Cerebellar hemorrhage | Emergent CT; neurosurgery consult; blood pressure management |
| Sudden onset + vascular risk factors + vertigo | Cerebellar ischemic stroke | CT to rule out hemorrhage; MRI/MRA; thrombolysis if eligible |
| Acute vertigo + positive head impulse test + unidirectional nystagmus | Vestibular neuritis (peripheral) | Supportive care; steroids may help; reassurance about recovery |
| Acute vertigo + normal head impulse + direction-changing nystagmus | Central cause (cerebellar stroke) | Emergent MRI; stroke workup; HINTS more sensitive than early MRI |
| Ataxia + confusion + ophthalmoplegia + malnourished/alcohol use | Wernicke encephalopathy | IV thiamine 500 mg TID immediately; MRI may show mammillary body changes |
| Ataxia + recent dose change of anticonvulsant | Medication toxicity | Check drug levels; hold or reduce dose; usually reversible |
| Ataxia + areflexia + ophthalmoplegia + recent GI illness | Miller Fisher syndrome | Anti-GQ1b antibodies; monitor respiratory function; IVIg if progressing |
| Ataxia following viral illness (especially varicella) | Post-infectious cerebellitis | MRI; CSF analysis; usually self-limiting; supportive care |
Algorithm B: Subacute Ataxia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Subacute ataxia + smoking history + weight loss | Paraneoplastic cerebellar degeneration | Paraneoplastic panel; CT chest/abdomen/pelvis; PET-CT; treat cancer if found |
| Subacute ataxia + known malignancy | Paraneoplastic or metastatic disease | MRI brain with contrast; paraneoplastic antibodies; restage cancer |
| Subacute ataxia + type 1 diabetes or thyroid disease | Anti-GAD associated cerebellitis | Anti-GAD antibodies; trial of immunotherapy (steroids, IVIg) |
| Subacute ataxia + rapid cognitive decline + myoclonus | Creutzfeldt-Jakob disease | MRI (DWI); EEG; CSF RT-QuIC; no treatment but important for infection control |
| Subacute ataxia + immunocompromised | PML, CNS lymphoma, opportunistic infection | MRI; LP with JC virus PCR, cytology; check HIV status |
| Subacute ataxia + GI symptoms or malabsorption | Vitamin deficiency (B12, E) or gluten ataxia | Check B12, vitamin E, anti-gliadin antibodies; empiric replacement |
Algorithm C: Chronic Ataxia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Chronic ataxia + heavy alcohol use + gait > limb involvement | Alcoholic cerebellar degeneration | MRI (vermis atrophy); thiamine replacement; alcohol cessation; may stabilize |
| Chronic ataxia + positive family history (autosomal dominant) | Spinocerebellar ataxia | SCA genetic panel; genetic counseling; symptomatic treatment |
| Onset before age 25 + scoliosis + pes cavus + cardiomyopathy | Friedreich ataxia | FXN gene testing; echocardiogram; consider omaveloxolone |
| Chronic ataxia + autonomic failure + parkinsonism | Multiple system atrophy | MRI (“hot cross bun” sign); autonomic testing; supportive care |
| Chronic ataxia + relapsing neurological symptoms | Multiple sclerosis | MRI brain and spine; LP for oligoclonal bands; disease-modifying therapy |
| Late-onset (>50) + no family history + negative workup | Idiopathic late-onset cerebellar ataxia | Diagnosis of exclusion; continue surveillance; symptomatic treatment |
| Episodic attacks with complete recovery between | Episodic ataxia (channelopathy) | Genetic testing (CACNA1A, KCNA1); trial of acetazolamide |
Step 4: Determine Ataxia Type
| Feature | Cerebellar Ataxia | Sensory Ataxia | Vestibular Ataxia |
|---|---|---|---|
| Romberg test | Negative (minimal change with eye closure) | Positive (marked worsening with eye closure) | May worsen slightly; directional falling |
| Gait pattern | Wide-based, lurching, irregular | Stomping, high-stepping, looking at feet | Veering to one side; relatively narrow base |
| Limb coordination | Dysmetria, intention tremor, dysdiadochokinesia | Pseudoathetosis; worsens without visual feedback | Usually preserved |
| Speech | Scanning dysarthria (slurred, irregular) | Normal | Normal |
| Nystagmus | Gaze-evoked; multidirectional; does not suppress | Absent | Present; direction-fixed (peripheral) or direction-changing (central) |
| Vertigo | Usually absent | Absent | Prominent |
| Sensory examination | Normal | Loss of vibration and proprioception | Normal |
| Next investigation | MRI brain (cerebellum) | B12, vitamin E; nerve conduction studies; MRI spine | HINTS exam; audiometry; MRI if central features |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| MRI shows cerebellar stroke | Stroke protocol; assess for thrombolysis/thrombectomy eligibility | Monitor for swelling; neurosurgery standby; secondary prevention |
| MRI shows cerebellar mass | Assess for mass effect and hydrocephalus | Neurosurgery and oncology consults; staging workup; biopsy vs resection |
| MRI shows cerebellar atrophy only | Continue systematic workup | Genetic testing if hereditary suspected; paraneoplastic panel; anti-GAD |
| Paraneoplastic antibodies positive but no cancer found | Begin immunotherapy (steroids, IVIg, or rituximab) | PET-CT; repeat cancer screening every 3-6 months for 2 years |
| Anti-GAD antibodies strongly positive | Trial of immunotherapy | Screen for associated conditions (type 1 diabetes, thyroid disease) |
| Genetic testing positive for hereditary ataxia | Confirm diagnosis; counsel patient | Genetic counseling for family; assess for associated features; clinical trial eligibility |
| All investigations negative | Review history and examination; consider repeat MRI | Trial of gluten-free diet if anti-gliadin positive; empiric immunotherapy if autoimmune suspected; long-term follow-up |
Troubleshooting Refractory or Unexplained Ataxia
Ask These Questions
- Is the diagnosis correct? Re-examine to confirm true ataxia vs weakness, apraxia, or functional disorder
- Was the workup comprehensive? Review for missed causes: gluten ataxia, anti-GAD, vitamin E, superficial siderosis
- Is there an occult malignancy? Consider repeat imaging or PET-CT; some cancers remain occult for years
- Could this be hereditary without family history? De novo mutations occur; recessive conditions may have no affected relatives
- Are there multiple contributing factors? Alcohol + medication + nutritional deficiency
- Was enough time given for empiric treatments? Gluten-free diet needs 6-12 months; B12 replacement may take months to show effect
- Is the patient taking all medications as prescribed? Non-adherence to disease-modifying therapy; continued alcohol or toxin exposure
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The Romberg test is your key discriminator: Positive Romberg (marked worsening with eye closure) indicates sensory ataxia; negative Romberg points to cerebellar ataxia. This single test fundamentally redirects your workup.
Thiamine first, always: In any patient with ataxia and altered mental status or eye movement abnormalities, give IV thiamine before glucose. Glucose administration can precipitate or worsen Wernicke encephalopathy in thiamine-deficient patients.
HINTS beats MRI early: In acute vestibular syndrome, the HINTS examination (Head Impulse, Nystagmus, Test of Skew) is more sensitive than MRI in the first 24-48 hours for detecting cerebellar stroke. A “central” HINTS pattern requires urgent evaluation even if initial MRI is negative.
Subacute ataxia is paraneoplastic until proven otherwise: When ataxia develops over days to weeks, aggressively search for malignancy. The cerebellar syndrome often precedes cancer diagnosis by months. Repeat cancer screening every 3-6 months if antibodies are positive but no tumor is found.
Check drug levels even at “therapeutic” doses: Chronic phenytoin use can cause irreversible cerebellar damage even with levels in the therapeutic range. Cumulative toxicity matters more than any single level.
Gluten ataxia exists without gut symptoms: Up to 15% of idiopathic ataxias may be gluten-related, and many patients have no gastrointestinal symptoms. Check anti-gliadin antibodies in unexplained ataxia and consider a strict gluten-free diet trial for 6-12 months.
Cerebellar hemorrhage is a neurosurgical emergency: Posterior fossa hemorrhage can cause rapid deterioration due to brainstem compression and obstructive hydrocephalus. Early neurosurgical consultation is essential; decompressive surgery can be life-saving.
Friedreich ataxia is more than just ataxia: Screen for cardiomyopathy (the leading cause of death), diabetes, scoliosis, and vision/hearing problems. Multidisciplinary care significantly improves outcomes. Omaveloxolone is now FDA-approved for treatment.
Critical Pitfalls to Avoid
Missing cerebellar stroke because the patient “just has vertigo”: Cerebellar strokes often present with vertigo, nausea, and imbalance — symptoms easily attributed to peripheral vestibular disorders. Always perform the HINTS examination and have a low threshold for imaging in patients with vascular risk factors.
Giving glucose before thiamine: This is a classic and preventable error. In patients with potential Wernicke encephalopathy, glucose administration can deplete remaining thiamine stores and precipitate irreversible damage. Always give thiamine first.
Assuming negative family history rules out hereditary ataxia: Autosomal recessive conditions (like Friedreich ataxia) may have no other affected family members. De novo mutations occur in dominant conditions. Incomplete penetrance and anticipation can obscure family history.
Stopping the workup after finding one cause: Multiple etiologies can coexist. A patient with alcoholic cerebellar degeneration may also have thiamine deficiency, B12 deficiency, and drug toxicity. Address all contributing factors.
Trusting a normal early MRI in acute vestibular syndrome: MRI can be falsely negative in the first 24-48 hours after cerebellar stroke. If clinical suspicion is high (central HINTS pattern), repeat imaging in 24-48 hours or proceed with treatment despite negative initial MRI.
Delaying paraneoplastic workup: In paraneoplastic cerebellar degeneration, neurological damage often becomes irreversible within weeks. Early identification and treatment of the underlying malignancy offers the best chance of stabilization. Do not wait for the ataxia to “declare itself.”
Attributing all ataxia in alcoholics to alcohol: While alcoholic cerebellar degeneration is common, patients with alcohol use disorder are also at risk for Wernicke encephalopathy, B12 deficiency, hepatic encephalopathy, subdural hematoma, and other treatable conditions. Do not anchor on the obvious.
Forgetting that lithium toxicity can be permanent: Unlike most drug-induced ataxias, lithium can cause irreversible cerebellar damage. Even after levels normalize, ataxia may persist. Monitor patients on lithium closely and educate them about signs of toxicity.
Key Takeaways
- First, classify the ataxia type: Use the Romberg test, sensory examination, and presence of vertigo to distinguish cerebellar, sensory, and vestibular ataxia — this fundamentally directs the workup.
- Temporal profile is everything: Sudden onset suggests vascular emergency; subacute progression raises concern for paraneoplastic, autoimmune, or prion disease; chronic course points to hereditary or degenerative causes.
- Treat empirically when indicated: Give thiamine immediately if Wernicke encephalopathy is possible; do not wait for laboratory confirmation. Replace B12 if deficiency is suspected. Try acetazolamide in episodic ataxia.
- The HINTS examination can be life-saving: In acute vestibular syndrome, a central HINTS pattern (normal head impulse, direction-changing nystagmus, or skew deviation) indicates cerebellar stroke even when MRI is initially negative.
- Search aggressively for malignancy in subacute ataxia: Paraneoplastic cerebellar degeneration often precedes cancer diagnosis. Order paraneoplastic antibodies and comprehensive cancer screening; repeat imaging if initial workup is negative.
- Consider treatable autoimmune causes: Anti-GAD cerebellitis and gluten ataxia are underdiagnosed and potentially responsive to treatment. Include these in the workup of unexplained ataxia.
- Drug-induced ataxia is common and often reversible: Always review the medication list. Phenytoin, carbamazepine, lithium, and benzodiazepines are common culprits. Check levels and consider dose reduction or discontinuation.
- Hereditary ataxias require comprehensive care: Beyond neurological management, screen for associated features (cardiomyopathy in Friedreich ataxia, immunodeficiency in ataxia-telangiectasia) and provide genetic counseling.
- Rehabilitation matters: Even when disease-modifying treatment is not available, physical therapy, occupational therapy, and speech therapy can significantly improve function and quality of life.
- Do not forget cerebellar cognitive affective syndrome: Cerebellar lesions can cause executive dysfunction, personality changes, and language difficulties. Assess for neuropsychiatric symptoms and provide appropriate support.
Quick Reference Algorithm
Systematic Approach to Ataxia:
- Assess urgency: Sudden onset with headache or decreased consciousness? → Emergent imaging. Confusion with eye movement abnormalities? → Give IV thiamine immediately.
- Determine ataxia type: Perform Romberg test, sensory examination, and assess for vertigo. Cerebellar (Romberg negative) vs sensory (Romberg positive) vs vestibular (vertigo present).
- Establish temporal profile: Acute (hours-days), subacute (days-weeks), or chronic (months-years). This narrows the differential dramatically.
- Order baseline investigations: MRI brain, B12, vitamin E, thyroid function, comprehensive metabolic panel. Check drug levels if on anticonvulsants or lithium.
- Pursue targeted workup based on clinical scenario: Paraneoplastic panel and cancer screening if subacute; genetic testing if hereditary pattern; autonomic testing if MSA suspected.
- Consider empiric treatment trials: Thiamine in suspected Wernicke; gluten-free diet if anti-gliadin positive; acetazolamide in episodic ataxia; immunotherapy if autoimmune cerebellitis suspected.
- Provide comprehensive care: Rehabilitation services; genetic counseling if hereditary; screening for associated conditions; fall prevention; quality of life support.